(BIKO) Benign Prostatic Hyperplasia.pptx

narpatisesa 18 views 18 slides Jun 10, 2024
Slide 1
Slide 1 of 18
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18

About This Presentation

BPH


Slide Content

Benign Prostatic Hyperplasia

Anatomy & Physiology The prostate is a part of the male reproductive system, its function is to produce semen fluid, which serves as a transport for sperm. It is located under the bladder , in the center of which is the urethra, a channel that carries urine from the bladder out through the penis. The normal size of the prostate in adult men is 15-20 cc

Terminology BPH = benign prostatic hyperplasia; BPE = benign prostatic enlargement; BPO = benign prostatic obstruction; BOO = bladder outlet obstruction

BPH/LUTS Pathophysiology

Initial Evaluation Detailed medical history Symptom assessment (AUA-SS or IPSS) Physical exam, including DRE and neurologic exam Urinalysis PSA

LUTS Symptoms attributable to lower urinary tract dysfunction storage (irritative) symptoms emptying (obstructive) symptoms may be associated with BPH, BPE, and BPO, but not exclusive to these

International Prostate Symptom Score

Goals of Therapy for BPH BPH Treatment Success measured by: ↓ symptoms (IPSS/AUA) ↓ bother (bother score) and ↑ QOL ↓ prostate size or arrest further growth ↑Increase in peak flow rate / Relieve obstruction Prevention of long-term outcomes/complications Acceptable adverse events profile

Medical Treatment Alpha-adrenergic blockers Dynamic component 5 - alpha reductase inhibitors Anatomic component Anticholinergic Therapy

Agent Dosing Titration Uroselective Terazosin (Hytrin ® ) 1 mg, 2 mg, 5 mg, 10 mg, 20 mg + NO Doxazosin (Cardura ® ) 1 mg, 2 mg, 4 mg, 8 mg, 16 mg + NO Tamsulosin (Flomax ® ) 0.4 mg, 0.8 mg +/- (for improved efficacy) YES (Relative affinity for a 1A receptors over a 1B ) Alfuzosin 10 mg - YES (Highly diffused in prostatic tissue vs serum)

Surgical Therapy Absolute Indications : None Relative Indications : Symptoms AUR Bleeding Bladder Calculus UTI Renal Insufficiency

Advantages : Availability of long-term outcomes data Good clinical results Treats prostates <150 g Low retreatment rate Low mortality Transurethral Resection of the Prostate (TURP) Disadvantages : Retrograde ejaculation Bleeding TUR Syndrome Catheter time Hospital Stay
Tags